A trial to study the effectiveness and survival-on-drug of certolizumab pegol in a real-life setting, both in TNFi-naive patients and in patients who had previously failed TNFis, and in relation to disease activity at baseline.
Phase of Trial: Phase IV
Latest Information Update: 20 May 2016
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 20 May 2016 New trial record